Skip to content
Search

Latest Stories

Long Covid more common in those bedridden for at least seven days during infection

The increase in prevalence of symptoms was noted regardless of gender, age groups, existence of depressive, anxiety or Covid-19 related distress symptoms, or pre-existing comorbidity

Long Covid more common in those bedridden for at least seven days during infection

Those people who were bedridden for at least seven days during a Covid-19 infection experienced severe physical symptoms of the disease persisting for up to two years after diagnosis, new research in The Lancet Regional Health-Europe journal has found.

A team of researchers from Karolinska Institutet, Sweden, discovered that these individuals exhibited 37 per cent higher chronic symptoms associated with long Covid such as shortness of breath, chest pain, dizziness, headaches, and fatigue, in comparison to those who had not been diagnosed with the disease.


The increase in prevalence of symptoms was noted regardless of gender, age groups, existence of depressive, anxiety or Covid-19 related distress symptoms, or pre-existing comorbidity. The rise was higher among individuals without depressive or anxiety symptoms, the researchers said.

A higher prevalence was also observed among individuals hospitalised for Covid-19 from two months to 22 months following diagnosis, they said.

The study comprised 64,880 adults from Sweden, Denmark, Norway and Iceland with self-reported physical symptoms between April, 2020 and August, 2022. Of these, over 22,000 (34.5 per cent) were diagnosed with Covid-19 during the period, with nearly 10 per cent of them being bedridden for at least seven days.

The World Health Organisation (WHO) defines long Covid as a condition whereby symptoms continue to prevail or develop three months after the initial SARS-CoV-2 infection, sometimes lasting for at least two months with no other explanation.

Studies show that around 10-20 per cent of people infected by Covid-19 may go on to develop symptoms that can be diagnosed as long Covid, the WHO said in a factsheet issued in December, 2022.

"Long Covid has grown into a major public health problem since a large proportion of the global population has been infected," said Emily Joyce, a doctoral student at the Institute of Environmental Medicine, Karolinska Institutet, and one of the study's first authors.

"Our results show the long-term health consequences of the pandemic and highlight the importance of monitoring physical symptoms for up to two years after diagnosis, especially in people who experienced severe Covid-19," said Joyce.

In this study, the majority of the participants were fully or partially vaccinated, and the results were largely the same in analyses of exclusively vaccinated individuals, the researchers said.

They also said that the participants not bedridden during their infection presented with a similar prevalence to people who had not been diagnosed with Covid-19.

"We'll continue to assess the long-term health impact of the Covid-19 pandemic in this project," said corresponding author Qing Shen, affiliated researcher at Karolinska Institutet.

"Multiple projects are underway, including studies of how Covid-19 has affected cognitive function and mental health, and how social isolation affected the elderly," said Shen.

(PTI)

More For You

Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
Gen Z

These terms provide insight into how Gen Z views the world around them

iStock

11 Gen Z slang terms that have already peaked in 2025

Language is constantly evolving, and nowhere is this more apparent than in the lexicon of Gen Z. As the first generation to grow up fully immersed in social media, their language is influenced by memes, viral videos, and digital culture. With 2025 underway, several Gen Z slang terms have already become ubiquitous, appearing in everyday conversations, on social media platforms, and even in mainstream media. Here are 11 slang terms that have already peaked this year.

1. Delulu

"Delulu," short for "delusional," is one of the most prominent slang terms of 2025. It’s used to describe someone who holds unrealistic beliefs or makes outlandish claims. The term was catapulted into the spotlight after Australian Prime Minister Anthony Albanese used it in Parliament to describe his political opponents, referring to them as being "delulu with no solulu," which translates to "delusional with no solution." The term has since been widely adopted by young people, particularly in online communities. It’s now frequently used to poke fun at someone’s exaggerated or disconnected views on social media.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less
Global Nursing Inequality Exposed in New Report on Nurses Day

The WHO forecasts a continued reduction in the global nursing shortage

iStock

International Nurses Day: Report shows the poorest regions face 70% shortages of nurses

The global nursing workforce has grown by nearly two million over the past five years, yet major disparities in distribution continue to impede progress towards universal health coverage (UHC) and global health goals, according to the State of the World’s Nursing 2025 report released on 12 May by the World Health Organization (WHO), International Council of Nurses (ICN), and partners.

As of 2023, there are 29.8 million nurses worldwide, up from 27.9 million in 2018. The report also notes a decline in the global nursing shortage, from 6.2 million in 2020 to 5.8 million in 2023. However, the report cautions that the improvements are not evenly shared across regions and income levels, leaving many low- and middle-income countries struggling with persistent shortfalls.

Keep ReadingShow less